Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Revenue (2016 - 2025)

Historic Revenue for Outlook Therapeutics (OTLK) over the last 7 years, with Q3 2025 value amounting to -$91787.0.

  • Outlook Therapeutics' Revenue changed N/A to -$91787.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $1.4 million, marking a year-over-year increase of 18135.73%. This contributed to the annual value of $1.4 million for FY2025, which is 14477.51% up from last year.
  • Per Outlook Therapeutics' latest filing, its Revenue stood at -$91787.0 for Q3 2025.
  • Over the past 5 years, Outlook Therapeutics' Revenue peaked at $1.5 million during Q2 2025, and registered a low of -$91787.0 during Q3 2025.